From the Journals
Despite HCV cure, liver cancer-associated genetic changes persist
News
Conference Coverage
HCV treatment with DAA regimens linked to reduced diabetes risk
Diabetes incidence was lower in hepatitis C patients treated with DAAs than in untreated patients.
From the Journals
Developing an HCV vaccine faces significant challenges
From the Journals
Possible biomarkers found for progression to liver cancer in chronic HCV infection
Mannose-binding lectin and ficolin-2 are potential biomarkers for the development of liver cancer in chronic HCV infection.
From the Journals
Baby boomers account for more than 74% of chronic HCV cases
From the Journals
DAAs reduce mortality, cancer risk in HCV study
Large, prospective study showed direct-acting antivirals reduced mortality and cancer risk in chronic HCV-infected patients.
From the Journals
Host stress response may be a factor in early-stage HCV clearance
From the Journals
Young opioid users in NYC savvy about HCV
From the Journals
Vitamin D–binding protein polymorphisms affect HCV susceptibility
Conference Coverage
It’s time for universal HCV screening in the ED
SAN FRANCISCO –
Conference Coverage
Hepatitis C debrief: Therapy has matured, access issues remain
Hepatitis C virus treatments are now broadly available, but challenges remain in getting the treatments to those who need them.
Conference Coverage
Hep C–infected livers are safe for transplant
SAN FRANCISCO – An analysis shows no difference in graft survival or overall survival when a donated liver is...
Conference Coverage
High rates of HCV treatment completion seen in people who inject drugs
Treatment of people who inject drugs will help prevent new cases of HCV, study coauthor maintains.
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.